NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
Post-LOEnorethindrone and ethinyl estradiol and ferrous fumarate
ANDAORALTABLET, CHEWABLE
Approved
Apr 2014
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (norethindrone and ethinyl estradiol and ferrous fumarate) by Aurobindo Pharma is ovulation. First approved in 2014.
Drug data last refreshed 18h ago
Mechanism of Action
ovulation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.